We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




New Device Shortens Chest-Tube Insertion Time

By HospiMedica International staff writers
Posted on 06 Apr 2016
A novel one-handed thoracic portal opener dramatically shortens chest-tube insertion procedure time when treating pneumothorax.

Developed by researchers of the BioDesign team at the Hebrew University (HUJI; Jerusalem, Israel) and Hadassah Medical Center (Jerusalem, Israel), the ThoraXS is a closed, knife-shape device that permits fast penetration of the pleural space, and a mechanical opening mechanism that enables the rapid opening of a gateway in the thorax through which a chest tube (or intercostal drain) can be quickly inserted, usually in the area under the axilla where damage to internal organs can be avoided. More...


In traumatic pneumothorax, larger bore tubes are inserted than in spontaneous pneumothorax, which are connected to a one-way valve system that allows air to escape, but not to re-enter, the chest. This may include a bottle of water that functions as a water seal, or a unidirectional Heimlich valve. Patients are evacuated with the chest tube in place for further treatment in a hospital. Development of the ThoraXS was initiated following the recent wave of knifing terrorist attacks in Israel.

“The current procedure involves two steps; a fast needle decompression of the cavity, followed by a slow, 15-minute procedure to insert the chest tube and secure the lung permanently,” said device co-developer Ariel Drori, MD, an internal medicine expert at Hadassah Medical Center. “This is a very laborious and technically difficult procedure, leading caregivers to neglect the second step in favor of rapid evacuation from the scene to the hospital.”

“Our students responded to terror attacks by developing life-saving medical devices, an approach that is the very essence of our BioDesign medical innovation program,” said Prof. Yaakov Nahmias, PhD, director of the HUJI BioDesign center for bioengineering. “ThoraXS is a life-saving innovation that exemplifies our commitment to helping the local and global communities through practical research and development projects.”

Pneumothorax is a medical emergency resulting from an abnormal collection of air or gas in the pleural space that causes an uncoupling of the lung from the chest wall, causing it to collapse and resulting in suffocation. A traumatic pneumothorax may result from either blunt trauma (such as an explosion) or a penetrating injury to the chest wall.

Related Links:

Hebrew University
Hadassah Medical Center



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Portable Ventilator
Oxivent Oxi4Plus
New
MR Trolley
MR9002
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: New clinical guidance suggests treatments to prevent blood clots in CLTI patients after leg artery procedures (Photo courtesy of Shutterstock)

Stronger Blood Clot Prevention Measures Needed After Leg Artery Procedures in High-Risk Patients

Chronic limb-threatening ischemia (CLTI), the most severe form of peripheral artery disease (PAD), significantly reduces blood flow to the legs and feet. Despite undergoing lower limb revascularization... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.